NCT00589602 2017-05-30
T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases
The Cleveland Clinic
Phase 2 Terminated
The Cleveland Clinic
Rutgers, The State University of New Jersey
Barbara Ann Karmanos Cancer Institute
Mayo Clinic
British Columbia Cancer Agency